Literature DB >> 1829873

Non-Hodgkin lymphoma in common variable immunodeficiency.

C Cunningham-Rundles1, P Lieberman, G Hellman, R S Chaganti.   

Abstract

The association between cancer and immunodeficiency is well established. In common variable immunodeficiency (CVI), a primary immunodeficiency disease characterized by low serum immunoglobulins and poor antibody production, we previously reported a total of 13 cancers in 11 individuals arising in continuously observed group of patients. Of the 13, 7 were NHL and 1 was a myeloma which progressed to lymphoma. We report here the histologic, immunologic, cytogenetic, and clinical features of these 8 NHL along with 3 new lymphomas which have appeared in this group (now 117 patients). From our studies, the lymphomas which have arisen in CVI share certain features with the lymphomas which appear in the childhood immunodeficient syndromes. Wiskott Aldrich Syndrome, Ataxia Telangiectasia, or severe combined immunodeficiency: they are similar in overall frequency (13%), are often B-cell in origin, and extranodal in location. However, unlike the lymphomas of the immunodeficient child, lymphomas in CVI may be more differentiated and secrete immunoglobulin. For CVI patients with stage I or II disease, as for non-Hodgkin lymphomas in general, the prognosis is good. In our group, NHL in CVI have appeared most often in females of the 5th to 7th decade and not in childhood. Cytogenetic studies in lymphomas show that cytogenic abnormalities, including chromosomal translocation, can be found in this group, but more studies will be needed to assess the frequency of these events.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1829873     DOI: 10.1002/ajh.2830370202

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  20 in total

Review 1.  Common variable immune deficiency: Dissection of the variable.

Authors:  Charlotte Cunningham-Rundles
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

2.  Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID).

Authors:  Nicole M Chase; James W Verbsky; Mary K Hintermeyer; Jill K Waukau; Aoy Tomita-Mitchell; James T Casper; Sumit Singh; Kaushik S Shahir; William B Tisol; Melodee L Nugent; R Nagarjun Rao; A Craig Mackinnon; Lawrence R Goodman; Pippa M Simpson; John M Routes
Journal:  J Clin Immunol       Date:  2012-08-29       Impact factor: 8.317

3.  Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency.

Authors:  Asghar Aghamohammadi; Abolhasan Farhoudi; Mostafa Moin; Nima Rezaei; Ali Kouhi; Zahra Pourpak; Nima Yaseri; Masoud Movahedi; Mohammad Gharagozlou; Fariborz Zandieh; Fereshteh Yazadni; Saba Arshi; Iraj Mohammadzadeh; Bahram Mirsaeid Ghazi; Maryam Mahmoudi; Seyedamir Tahaei; Anna Isaeian
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

4.  Morbidity and mortality in common variable immune deficiency over 4 decades.

Authors:  Elena S Resnick; Erin L Moshier; James H Godbold; Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2011-12-16       Impact factor: 22.113

Review 5.  The many faces of common variable immunodeficiency.

Authors:  Charlotte Cunningham-Rundles
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

6.  Common variable immunodeficiency.

Authors:  Jonathan S Tam; John M Routes
Journal:  Am J Rhinol Allergy       Date:  2013 Jul-Aug       Impact factor: 2.467

Review 7.  Common Variable Immunodeficiency.

Authors:  Biman Saikia; Sudhir Gupta
Journal:  Indian J Pediatr       Date:  2016-02-12       Impact factor: 1.967

8.  Common variable immunodeficiency (CVID) and MxA-protein expression in blood leucocytes.

Authors:  J A Rump; D Jakschiess; U Walker; M Schlesier; P von Wussow; H H Peter
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

Review 9.  Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review.

Authors:  P Wood; S Stanworth; J Burton; A Jones; D G Peckham; T Green; C Hyde; H Chapel
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

10.  Lymphoproliferative disease in antibody deficiency: a multi-centre study.

Authors:  M M Gompels; E Hodges; R J Lock; B Angus; H White; A Larkin; H M Chapel; G P Spickett; S A Misbah; J L Smith
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.